HomeInsightsStock Comparison

Aarey Drugs Pharmaceuticals Ltd vs Trident Lifeline Ltd Stock Comparison

Aarey Drugs Pharmaceuticals Ltd vs Trident Lifeline Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 54.61 as of 12 Jun 15:30.
  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 0 as of March 2022 .The P/E Ratio of Trident Lifeline Ltd is 0 as of March 2022.
  • The Market Cap of Aarey Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Trident Lifeline Ltd is ₹ 0 crore as of March 2022.
  • The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Trident Lifeline Ltd for the Mar '25 is ₹ 52.68 crore as compare to the Dec '24 revenue of ₹ 12.39 crore. This represent the growth of 325.18%.
  • The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Trident Lifeline Ltd for the Mar '25 is ₹ 10.02 crore as compare to the Dec '24 ebitda of ₹ 4.64 crore. This represent the growth of 115.95%.
  • The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Trident Lifeline Ltd changed from ₹ 1.4 crore to ₹ 3.76 crore over 8 quarters. This represents a CAGR of 63.88% .
  • The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarey Drugs & Pharmaceuticals Ltd

  • Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
  • In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
  • Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
  • The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Trident Lifeline Ltd

  • Trident Lifeline Limited was originally incorporated as Private Limited Company under the name 'Trident Lifeline Private Limited' on January 09, 2014.
  • Subsequently, Company converted into a Public Limited pursuant to Shareholders' Resolution on June 02, 2022 and name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
  • The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
  • It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
  • It operate in India as well as African, Latin American and East Indian Countries.

Aarey Drugs & Pharmaceuticals Ltd News Hub

News

Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

23 May 2025 20:23

News

Aarey Drugs & Pharmaceuticals to declare Quarterly Results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

07 Feb 2025 15:41

News

Aarey Drugs & Pharmaceuticals schedules EGM

Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of th...

Read more

05 Dec 2024 17:27

News

Aarey Drugs & Pharmaceuticals anounces board meeting date

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

30 Nov 2024 14:47

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

27 Nov 2024 09:36

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

07 Nov 2024 14:25

Trident Lifeline Ltd News Hub

News

Trident Lifeline to convene board meeting

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 28 April ...

Read more

23 Apr 2025 10:16

News

Trident Lifeline to convene EGM

Trident Lifeline announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

17 Apr 2025 16:03

News

Trident Lifeline jumps on collaboration with NIPER-A for Vorinostat, a rare cancer drug

According to an exchange filing, the alliance focuses on transferring the technology for V...

Read more

06 Mar 2025 11:28

News

Trident Lifeline to discuss results

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 22 Januar...

Read more

17 Jan 2025 11:05

News

Trident Lifeline to announce Quarterly Result

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 19 Octobe...

Read more

16 Oct 2024 12:46

News

Trident Lifeline to hold AGM

Trident Lifeline announced that the Annual General Meeting (AGM) of the company will be he...

Read more

09 Aug 2024 14:58

SWOT Analysis Of Trident Lifeline Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Aarey Drugs & Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarey Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Trident Lifeline Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Trident Lifeline Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 154 Cr while Market cap of Trident Lifeline Ltd is 304 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd?

As of June 13, 2025, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹54.61. On the other hand, Trident Lifeline Ltd stock price is INR ₹264.7.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions